Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
𝛼
SK
or Search
SIGN UP
SIGN IN
ENTITY
Bio Techne Corp (TECH US)
Watchlist
27
Analysis
Health Care
•
United States
Bio-Techne Corp develops, manufactures and sells biotechnology products and clinical diagnostic controls. The Company specializes in proteins, cytokines, growth factors, immunoassays and small molecules.
more
Watchlist
All
Insights
Primers
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Bio Techne Corp
•
25 May 2023 03:03
Bio-Techne Corporation: Collaboration With Lunaphore & Other Drivers
Bio-Techne had a weak quarter, with revenues below market expectations. Its revenue growth was not up to the mark despite the key drivers being...
Baptista Research
Follow
372 Views
Share
bullish
•
Bio Techne Corp
•
15 Feb 2023 01:22
Bio-Techne Corporation: Expansion RNAscope & Other Drivers
Bio-Techne delivered a disappointing result in the last quarter while failing to meet Wall Street expectations in terms of revenues as well as...
Baptista Research
Follow
325 Views
Share
bullish
•
Bio Techne Corp
•
18 Nov 2022 00:36
Bio-Techne Corp: Advanced Cell Diagnostics RNAscope System Developments & Other Drivers
Bio-Techne has been going through a tough 2022 and witnessed a slow summer especially in the European markets as well as Covid-related shutdowns...
Baptista Research
Follow
386 Views
Share
bullish
•
Bio Techne Corp
•
14 Jul 2022 01:05
Bio-Techne Corporation: Initiation of Coverage – The Namocell Acquisition & Other Developments
This is our first report on Bio-Techne Corporation. The company delivered a strong financial performance in the past quarter, surpassing Wall...
Baptista Research
Follow
144 Views
Share
bullish
•
Qiagen N.V.
•
21 Jul 2020 20:02
Qiagen/Thermo Fisher: Qiagen Gets a Bump – Is It Enough to Satisfy Shareholders?
QIAGEN NV (QIA GY) shares have gone from strength to strength with the stock trading above terms and then receiving a bump bid late last week....
Rickin Thakrar
Follow
596 Views
Share
First
Previous
2
3
4
5
6
Next
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
How Smartkarma Compares
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.4
x